“We are excited that Malaysia continues to be our base to serve Eppendorf’s clients in Southeast Asia and beyond. Therefore, and in order to continue further growing, we are very happy that we were able to move into the new facility at the Symphony Square,” said Eva van Pelt, Co-CEO of Eppendorf AG. “This newly integrated centre will be home to our shared services hub, covering functions such as IT, HR as well as Finance and Controlling, for the Group’s operations in the Asia Pacific (excluding China), Middle East and Africa. It is also home to the Southeast Asian sales and marketing operations of Eppendorf, and will enable us to support our customers in the region even better in the future.”
Further expanding the existing capacity, Eppendorf’s new office features a fully equipped demonstration area for Eppendorf products, a comprehensive on-site service and repair department as well as application laboratories and training areas. This centre is set up not only to host a broad group of the Eppendorf staff across the globe for annual training sessions on products and laboratory techniques, but it will also be open for customers to see and try out products in real laboratory settings, enhancing their overall customer experience.
Dato’ Azman Mahmud, Chief Executive Officer of the Malaysian Investment Development Authority (MIDA) congratulated Eppendorf on their significant milestone in Malaysia, “The evolution of the Eppendorf’s activities in Malaysia is in line with our aspirations to transition into a knowledge-based economy. We are proud that this new hub will employ more than 50 life scientists, engineers and other specialists providing technical and scientific application support, business intelligence, sales and marketing support and shared services. MIDA is constantly looking for opportunities to collaborate with commendable companies such as Eppendorf that bring frontier products and technology to our country. With this new venture, we look forward to Eppendorf taking this strategic partnership with Malaysia to the next level, further leveraging on the existing investment ecosystem and facilities to grow your business in the region.”
Currently, Eppendorf products are in particularly high demand in COVID-19 testing laboratories and test kit manufacturing facilities. Research facilities working on vaccines also utilise a wide range of Eppendorf products such as pipettes, centrifuges, automated liquid handling, CO2 incubators, consumables, freezers, shakers and dispensers.
For the period of January to June 2020, MIDA has approved 17 medical devices manufacturing projects worth RM2.0 billion (USD 0.5 billion). As of 2019, a total of 402 medical devices projects with investments worth RM20.5 billion (USD 5.6 billion) have been implemented in Malaysia, creating more than 76,500 jobs for the country.
Dato’ Azman highlighted that Malaysia continues to be the choice investment location, despite the current global uncertainty, “As a diversified economy with world-class infrastructure, Malaysia provides tremendous business opportunities, especially for global companies seeking to access the wider market in the Asia Pacific region. Investors, such as Eppendorf, are increasingly taking note of our competitive advantages given the unprecedented supply chain re-calibrations due to the current pandemic. MIDA looks to be at the forefront to entice more quality investments in the areas of technology and innovation to position Malaysia as an alternative supply chain hub in Asia.”
For more information, please contact:
Ms. Rosedalina Ramlan
Director, Business Services and Regional Operations (BRO) Division, MIDA
Email: [email protected] DL: +603 2267 3515
Ms. Shim Yok Lam
Zone Director, Eppendorf Southeast Asia
Email: [email protected] DL: +603 7610 5200
MIDA is the government's principal investment promotion and development agency under the Ministry of International Trade and Industry (MITI) to oversee and drive investments into the manufacturing and services sectors in Malaysia. Headquartered in Kuala Lumpur Sentral, MIDA has 12 regional and 20 overseas offices. MIDA continues to be the strategic partner to businesses in seizing the opportunities arising from the technology revolution of this era. For more information, please visit www.mida.gov.my and follow us on Twitter, Instagram, Facebook, LinkedIn and YouTube channel.
Eppendorf is a leading life science company that develops and sells instruments, consumables, and services for liquid, sample, and cell handling in laboratories worldwide. Its product range includes pipettes and automated pipetting systems, dispensers, centrifuges, mixers, spectrometers, and DNA amplification equipment as well as ultra-low temperature freezers, fermentors, bioreactors, CO2 incubators, shakers, and cell manipulation systems. Consumables such as pipette tips, test tubes, microtiter plates, and single-use bioreactors complement the range of highest-quality premium products.
Eppendorf products are most broadly used in academic and commercial research laboratories, e.g., in companies from the pharmaceutical and biotechnological as well as the chemical and food industries. They are also used in laboratories that perform clinical or environmental analysis, in forensic laboratories, and in industrial laboratories where process analysis, production and quality assurance are performed.
Eppendorf was founded in Hamburg, Germany in 1945 and currently has more than 4,000 employees worldwide. The company has subsidiaries in 26 countries and is represented in all its other important markets by distributors.